Holen Sie sich die Stockscreener-App
7.21
2.96%
-0.22
Handel nachbörslich:
7.21
Schlusskurs vom Vortag:
$7.43
Offen:
$7.41
24-Stunden-Volumen:
732.66K
Relative Volume:
0.71
Marktkapitalisierung:
$1.10B
Einnahmen:
$43.34M
Nettoeinkommen (Verlust:
$-247.99M
KGV:
-3.6529
EPS:
-1.9738
Netto-Cashflow:
$-224.28M
1W Leistung:
-6.73%
1M Leistung:
-17.97%
6M Leistung:
-30.87%
1J Leistung:
-30.41%
1-Tages-Spanne:
$7.14
$7.42
1-Wochen-Bereich:
$7.02
$7.81
52-Wochen-Spanne:
$7.02
$12.41
Immatics N V Stock (IMTX) Company Profile
Compare IMTX vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
7.21 | 1.10B | 43.34M | -247.99M | -224.28M | -1.9738 |
VRTX
Vertex Pharmaceuticals Inc
|
507.00 | 128.50B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
213.74 | 85.33B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
762.81 | 78.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
812.30 | 51.08B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
193.95 | 41.57B | 742.00K | -1.37B | -1.07B | -7.0731 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-28 | Eingeleitet | TD Cowen | Buy |
| 2026-03-16 | Fortgesetzt | Jefferies | Buy |
| 2025-09-18 | Eingeleitet | Guggenheim | Buy |
| 2025-05-28 | Eingeleitet | Deutsche Bank | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Overweight |
| 2023-11-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-31 | Eingeleitet | Mizuho | Buy |
| 2023-03-24 | Eingeleitet | Bryan Garnier | Buy |
| 2020-11-20 | Eingeleitet | BofA Securities | Buy |
| 2020-09-22 | Eingeleitet | Goldman | Buy |
| 2020-07-27 | Eingeleitet | SVB Leerink | Outperform |
| 2020-07-24 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Immatics N V Aktie (IMTX) Neueste Nachrichten
Immatics (IMTX) Slides 10% as Shares Test Key Support Near $7.21Chaikin Flow - siam.in
Immatics (NASDAQ:IMTX) Sets New 52-Week LowHere's What Happened - MarketBeat
Immatics (NASDAQ:IMTX) Shares Down 5.3%Here's What Happened - marketbeat.com
Immatics (Nasdaq:IMTX)Stock Analysis - Simply Wall Street
Immatics (NASDAQ:IMTX) Sees Unusually-High Trading VolumeStill a Buy? - marketbeat.com
Immatics (NASDAQ:IMTX) Stock Rating Upgraded by Wall Street Zen - marketbeat.com
Immatics (NASDAQ:IMTX) Sees Strong Trading VolumeWhat's Next? - marketbeat.com
Immatics stock falls 3.04 percent after cash raise and Q2 miss - AD HOC NEWS
Immatics N.V. (NASDAQ:IMTX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Price-Driven Insight from (IMTX) for Rule-Based Strategy - Stock Traders Daily
Immatics N.V. (IMTX) Holds at $9.43 as Shares Consolidate Above Key SupportShort Term Trading Ideas - vinanet.vn
Immatics stock holds near USD 9.60 after market cap update - ad-hoc-news.de
Immatics N.V. (IMTX) Holds at $9.43 as Shares Consolidate Above Key SupportHigh Reward Trades - dars.gov.et
Immatics N.V. Warrants (IMTXW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Immatics (NASDAQ:IMTX) Shares Up 5.3% on Insider Buying Activity - MarketBeat
Insider Buying: Immatics (NASDAQ:IMTX) Director Purchases 863,060 Shares of Stock - MarketBeat
Perceptive fund boosts Immatics (IMTX) stake with new open-market share buy - Stock Titan
Perceptive Advisors Acquires 863,060 Shares of Immatics N.V. at $8.69 Each - Kalkine Media
Immatics (NASDAQ: IMTX) gets 863K-share buy at $8.69 from Perceptive - Stock Titan
Trading Systems Reacting to (IMTX) Volatility - Stock Traders Daily
Immatics (NASDAQ: IMTX) raises fresh cash to fund oncology pipeline - Stock Titan
Form 424B2 Immatics N.V. - StreetInsider
Why is Immatics stock climbing today? - Investing.com India
Why is Immatics stock climbing today? By Investing.com - Investing.com Nigeria
Why is Immatics stock climbing today? By Investing.com - Investing.com UK
Immatics Announces $150 Million Underwritten Offering - Yahoo Finance
Immatics: 'Buy' On Anzu-Cel 1st Half 2027 Catalyst And Potential Label Expansion For Uveal Melanoma - Seeking Alpha
Immatics Announces $150 Million Underwritten Offering - GlobeNewswire
Immatics Announces $150 Million Underwritten Offering - Yahoo Finance
Why Immatics (IMTX) Is Down 5.4% After Mixed First‑Half 2026 Loss Trends And What's Next - simplywall.st
Immatics N.V. (NASDAQ:IMTX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
James Nelson Pepin Net Worth (2026) - GuruFocus
Immatics (NASDAQ:IMTX) Shares Down 8%Should You Sell? - MarketBeat
Immatics Announces Second Quarter 2026 Financial Results and Business Update - Sahm
Immatics (IMTX) awards counsel Nelson 225K share package - Stock Titan
Immatics Releases Q2 2026 Financial Results - AlphaStreet
Immatics Q2 revenue rises to $10.4 million - grafa.com
Immatics earnings on deck as analysts eye revenue trajectory By Investing.com - Investing.com India
Immatics earnings on deck as analysts eye revenue trajectory - Investing.com
Immatics earnings on deck as analysts eye revenue trajectory - Investing.com
Immatics Q2 Results: EPS misses estimate, sales up 93% YoY - scanx.trade
IMTX Looks 176.9% Overvalued on GF Value™ - GuruFocus
Immatics (NASDAQ:IMTX) Issues Earnings Results - MarketBeat
Immatics (IMTX) Slides 2.01% as Shares Approach Key $8.79 Support LevelQuality Factor - Vinanet
Immatics Posts Interim Q2 2026 Results and Updates Investor Materials - TipRanks
Immatics' Q2 Net Loss Narrows as Revenue Rises - marketscreener.com
Earnings Flash (IMTX) Immatics Posts Q2 Revenue 9.1M Euros, vs. FactSet Est of 10.4M Euros - marketscreener.com
Earnings Flash (IMTX) Immatics Posts Q2 Net Loss 0.46 Euros a Share, vs. FactSet Est of 0.45 Euros Loss - marketscreener.com
Immatics reports Q2 EPS (46c), consensus (48c) - TipRanks
Immatics: Q2 Earnings Snapshot - marketscreener.com
Finanzdaten der Immatics N V-Aktie (IMTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.73%
8.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):